Pfizer manager doing time for insider trading


Amit Dagar was charged in June 2023 with trading ahead of a November 2021 announcement that Paxlovid had reduced hospitalisations and deaths in high-risk patients by 89%, which sent the shares surging. — Reuters

NEW YORK: A former Pfizer Inc statistician was sentenced to nine months behind bars for making more than US$200,000 by trading on confidential information before a key announcement about the drugmaker’s Covid-19 treatment Paxlovid.

Amit Dagar, convicted of securities fraud and conspiracy after a one-week trial in January, was sentenced on Tuesday in a federal court in Manhattan by US District Judge Andrew L. Carter Jr.

He was charged in June 2023 with trading ahead of a November 2021 announcement that Paxlovid had reduced hospitalisations and deaths in high-risk patients by 89%, which sent the shares surging.

He had asked for a sentence of probation or home confinement.

The case is part of an effort by Manhattan US Attorney Damian Williams to crack down on corporate crime including insider trading.

The charges were announced the same day as the case against a trio of investors accused of trading on secret information about the merger plans of Digital World Acquisition Corp, the blank check company that took Donald Trump’s social media startup public. — Bloomberg

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Hong Kong stocks retreat on weak China data
Thai baht is too strong and impacting exports, minister says
Gold hits all-time high on deeper Fed rate cut expectations
PwC making investments for 'high quality' business in China, internal memo says
MPOB achieves 70% mapping coverage of oil palm smallholders in its nationwide plantation project
Oil prices inch up on Fed rate cut outlook
ALPS Global aims to raise US$100mil via Nasdaq IPO
Asia stocks on tenterhooks as Fed faces crunch time
PMB Technology to increase production
RGB hits jackpot post-pandemic

Others Also Read